Hyperkalemia Due to RAAS Inhibitors Best Treated by Stopping the Drugs
In a study, patients who experienced hyperkalemia while on a renin-angiotensin-aldosterone-system inhibitor had the lowest 1-year risk of recurrent hyperkalemia when the medication was discontinued.